Current practice for pulmonary hypertension

Objective To investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment. Data sources The review was based on data obtained from the published articles and guidelines. Study selection Articles with high level of evidence or current best evidenc...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2014, Vol.127 (19), p.3491-3495
Main Author: Satoh, Toru
Format: Article
Language:English
Subjects:
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - drug therapy
Hypertension, Pulmonary - epidemiology
基础研究
心脏疾病
数据来源
流行病学
磁共振成像
肺动脉高压
血管扩张剂
骨形态发生蛋白
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3495
container_issue 19
container_start_page 3491
container_title Chinese medical journal
container_volume 127
creator Satoh, Toru
description Objective To investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment. Data sources The review was based on data obtained from the published articles and guidelines. Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed. Results Overall prevalence of pulmonary hypertension was 0.3% to 6% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. In diagnosis, a flow diagram of diagnosis of pulmonary hypertension, differential diagnosis of pulmonary hypertension and how to determine the severity of pulmonary hypertension are explained including recent development of magnetic resonance imaging and gene abnormality study on bone morphogenetic protein receptor ll. In treatment, newly- developed pulmonary vasodilators and the way to use them are shown to treat pulmonary hypertension. Conclusion Safer and more effective treatment algorithm and basic researches and clinical trials are warranted to be explored.
doi_str_mv 10.3760/cma.j.issn.0366-6999.20140984
format article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj201419025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>662578993</cqvip_id><wanfj_id>zhcmj201419025</wanfj_id><sourcerecordid>zhcmj201419025</sourcerecordid><originalsourceid>FETCH-LOGICAL-c269t-b8a469e12a8b9bba7721712f7c27997f90c5fd6eede9368fc8962a680350a1963</originalsourceid><addsrcrecordid>eNo90F1LwzAUBuAgipvTvyBDUARpTdLmpOdShl8w8EavS5qlW0ubdkmLzF9vZJtXBw4P7-E9hNwyGicS6KNuVVzHlfc2pglABIgYc8pSill6QqZcpDwSkLJTMv0HE3LhfU0pF0LCOZlwwcOa4ZQ8LEbnjB3mvVN6qLSZl52b92PTdla53Xyz640bjPVVZy_JWakab64Oc0a-Xp4_F2_R8uP1ffG0jHRIHaIiUymgYVxlBRaFkpIzyXgpNZeIskSqRbkCY1YGE8hKnSFwBRlNBFUMIZmRu33ut7Klsuu87kZnw8X8Z6Pb-q8sw9AlwPs97F23HY0f8rby2jSNsqYbfc4ESCq4ABbo9YGORWtWee-qNvTLj58I4GYP9Kaz620Vzh4NABcyQ0ySX4-8bhM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1567052561</pqid></control><display><type>article</type><title>Current practice for pulmonary hypertension</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Satoh, Toru</creator><creatorcontrib>Satoh, Toru</creatorcontrib><description>Objective To investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment. Data sources The review was based on data obtained from the published articles and guidelines. Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed. Results Overall prevalence of pulmonary hypertension was 0.3% to 6% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. In diagnosis, a flow diagram of diagnosis of pulmonary hypertension, differential diagnosis of pulmonary hypertension and how to determine the severity of pulmonary hypertension are explained including recent development of magnetic resonance imaging and gene abnormality study on bone morphogenetic protein receptor ll. In treatment, newly- developed pulmonary vasodilators and the way to use them are shown to treat pulmonary hypertension. Conclusion Safer and more effective treatment algorithm and basic researches and clinical trials are warranted to be explored.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.20140984</identifier><identifier>PMID: 25269919</identifier><language>eng</language><publisher>China: Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan</publisher><subject>Humans ; Hypertension, Pulmonary - diagnosis ; Hypertension, Pulmonary - drug therapy ; Hypertension, Pulmonary - epidemiology ; 基础研究 ; 心脏疾病 ; 数据来源 ; 流行病学 ; 磁共振成像 ; 肺动脉高压 ; 血管扩张剂 ; 骨形态发生蛋白</subject><ispartof>Chinese medical journal, 2014, Vol.127 (19), p.3491-3495</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25269919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Satoh, Toru</creatorcontrib><title>Current practice for pulmonary hypertension</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Objective To investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment. Data sources The review was based on data obtained from the published articles and guidelines. Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed. Results Overall prevalence of pulmonary hypertension was 0.3% to 6% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. In diagnosis, a flow diagram of diagnosis of pulmonary hypertension, differential diagnosis of pulmonary hypertension and how to determine the severity of pulmonary hypertension are explained including recent development of magnetic resonance imaging and gene abnormality study on bone morphogenetic protein receptor ll. In treatment, newly- developed pulmonary vasodilators and the way to use them are shown to treat pulmonary hypertension. Conclusion Safer and more effective treatment algorithm and basic researches and clinical trials are warranted to be explored.</description><subject>Humans</subject><subject>Hypertension, Pulmonary - diagnosis</subject><subject>Hypertension, Pulmonary - drug therapy</subject><subject>Hypertension, Pulmonary - epidemiology</subject><subject>基础研究</subject><subject>心脏疾病</subject><subject>数据来源</subject><subject>流行病学</subject><subject>磁共振成像</subject><subject>肺动脉高压</subject><subject>血管扩张剂</subject><subject>骨形态发生蛋白</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo90F1LwzAUBuAgipvTvyBDUARpTdLmpOdShl8w8EavS5qlW0ubdkmLzF9vZJtXBw4P7-E9hNwyGicS6KNuVVzHlfc2pglABIgYc8pSill6QqZcpDwSkLJTMv0HE3LhfU0pF0LCOZlwwcOa4ZQ8LEbnjB3mvVN6qLSZl52b92PTdla53Xyz640bjPVVZy_JWakab64Oc0a-Xp4_F2_R8uP1ffG0jHRIHaIiUymgYVxlBRaFkpIzyXgpNZeIskSqRbkCY1YGE8hKnSFwBRlNBFUMIZmRu33ut7Klsuu87kZnw8X8Z6Pb-q8sw9AlwPs97F23HY0f8rby2jSNsqYbfc4ESCq4ABbo9YGORWtWee-qNvTLj58I4GYP9Kaz620Vzh4NABcyQ0ySX4-8bhM</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Satoh, Toru</creator><general>Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2014</creationdate><title>Current practice for pulmonary hypertension</title><author>Satoh, Toru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c269t-b8a469e12a8b9bba7721712f7c27997f90c5fd6eede9368fc8962a680350a1963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Humans</topic><topic>Hypertension, Pulmonary - diagnosis</topic><topic>Hypertension, Pulmonary - drug therapy</topic><topic>Hypertension, Pulmonary - epidemiology</topic><topic>基础研究</topic><topic>心脏疾病</topic><topic>数据来源</topic><topic>流行病学</topic><topic>磁共振成像</topic><topic>肺动脉高压</topic><topic>血管扩张剂</topic><topic>骨形态发生蛋白</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Satoh, Toru</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Satoh, Toru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current practice for pulmonary hypertension</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2014</date><risdate>2014</risdate><volume>127</volume><issue>19</issue><spage>3491</spage><epage>3495</epage><pages>3491-3495</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Objective To investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment. Data sources The review was based on data obtained from the published articles and guidelines. Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed. Results Overall prevalence of pulmonary hypertension was 0.3% to 6% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. In diagnosis, a flow diagram of diagnosis of pulmonary hypertension, differential diagnosis of pulmonary hypertension and how to determine the severity of pulmonary hypertension are explained including recent development of magnetic resonance imaging and gene abnormality study on bone morphogenetic protein receptor ll. In treatment, newly- developed pulmonary vasodilators and the way to use them are shown to treat pulmonary hypertension. Conclusion Safer and more effective treatment algorithm and basic researches and clinical trials are warranted to be explored.</abstract><cop>China</cop><pub>Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan</pub><pmid>25269919</pmid><doi>10.3760/cma.j.issn.0366-6999.20140984</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2014, Vol.127 (19), p.3491-3495
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj201419025
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - drug therapy
Hypertension, Pulmonary - epidemiology
基础研究
心脏疾病
数据来源
流行病学
磁共振成像
肺动脉高压
血管扩张剂
骨形态发生蛋白
title Current practice for pulmonary hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A03%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20practice%20for%20pulmonary%20hypertension&rft.jtitle=Chinese%20medical%20journal&rft.au=Satoh,%20Toru&rft.date=2014&rft.volume=127&rft.issue=19&rft.spage=3491&rft.epage=3495&rft.pages=3491-3495&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.20140984&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj201419025%3C/wanfang_jour_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c269t-b8a469e12a8b9bba7721712f7c27997f90c5fd6eede9368fc8962a680350a1963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1567052561&rft_id=info:pmid/25269919&rft_cqvip_id=662578993&rft_wanfj_id=zhcmj201419025&rfr_iscdi=true